Our Future Health - Links to follow. Some AI Use.
Our Future Health is a UK collaboration between the public sector, NHS, charities, and companies aimed at helping people live longer, healthier lives according to their blurb.
I received a letter from them today and they want 5 million British People to give them a sample of their DNA.
With Palantir a dystopian AI firm recently being awarded contracts across the UK in the military including our Nuclear weapons, the NHS where they now have access to all of our personal NHS Data including identifiable data and contracts across law enforcement agencies including the Metropolitan police I am worried about the direction the NHS is taking and who has access to my data and genetic information. I will not be contributing to the programme however who is to say they will not just take my DNA unlawfully the next time I have a blood test at my doctor's. They offered me a £10 Voucher to voluntarily participate in my enslavement.
Palantir is a company started by a hedge fund grant which was managed by Ehud Barak Ex Israeli Prime Minister and Jeffery Epstein. Epstein is said to invested tens of millions however Palantir say he was never an actual share holder.
If Palantir's AI targeting software which the Israeli Occupation Forces use to decide targets and decide an acceptable civilian death toll reportedly being up to 500 civilian deaths for just one militant target doesn't scare you enough the UK CEO of Palantir is none other than Oswald Mosely's (Rivers of Blood Speech Hitler Supporting Brown Shirt and Life long fascist) grandson.
For full Adams Family vibes to top it off a senior manager is Tony Blair's Son. A natural appointment considering Palantir's rise in UK Government Contracts began with Jeffery Epstein's long term best friend Labour grandee Lord Peter Mandelson when he was the Manager to Starmer's term in office
Epstein explicitly advised Barak to look into Thiel's data-analytics firm, Palantir, and suggested that Thiel could place Barak on Palantir's board. See further details on Palantir and the Epstein Project in my article, 'The Great Gold Robbery and the Yinon Plan'.
Equally when looking at a list of Our Future Healths commercial partners whilst it doesn't mention Palantir's involvement, the scale of their project and entering five million people's DNA sequences onto the National Health Data Base and analysing large amounts of health data will need an AI programme presumably Palantir's as it has the contracts for such a system and access to that data.
Palantir's main Institutional investors are
Top Institutional Shareholders
Vanguard Capital Management LLC: Holds 6.35% to 6.70%
BlackRock, Inc. (and BlackRock Advisors): Holds 6.34% to 8.70%
State Street Corporation: Holds 4.54% to 4.79%
Invesco Ltd. (Invesco Advisers / QQQ Trust): 3.06% to 3.23%
Geode Capital Management, LLC: Holds a prominent institutional stake of over 55 million shares.
Norges Bank Investment Management: Holds roughly 29 million to 31 million
The commercial, private, and industry partners associated with the Our Future Health research programme consist of 16 life sciences, pharmaceutical, and technology companies. Their list of owners is strikingly similar and shows how life and death are business partners as are the Pharmaceuticals and Healthcare businesses are intricately linked to the arms manufacturing business. The business of life and death are not just equally profitable they are run by the same companies.
Our Future Health Industry and Commercial Partners
1• AstraZeneca
Institutional investors
Vanguard Capital Management LLC: ~45.39 million shares (as of June 30, 2026)
Capital International Investors: ~34.58 million shares (as of June 30, 2026)
Norges Bank: ~33.86 million shares (as of June 30, 2026)
Capital World Investors: ~30.08 million shares
Fidelity Management & Research (FMR LLC): ~28.9 million shares
Wellington Management Group LLP: Major long-term holder
Investor AB: Long-standing major shareholder (~3.33% stake)
Legal & General Group Plc: Significant institutional asset manager position
Vanguard Capital Management LLC / Capital World Investors / Capital International Investors / Fidelity Management & Research (FMR LLC) / Wellington Management Group LLP: These massive asset managers collectively control trillions in capital. Due to their widespread index and mutual fund offerings, they hold major institutional ownership stakes in nearly every major international defense contractor, including industry giants like Lockheed Martin, RTX Corporation (formerly Raytheon), Boeing, and Northrop Grumman.
Norges Bank (NBIM): Norway’s sovereign wealth fund explicitly holds positions in several defense stocks, including Rheinmetall and Leonardo. While the fund historically maintained an ethical ban excluding 14 specific companies tied to nuclear weapons components (such as Airbus, Boeing, and BAE Systems), a government-appointed ethics committee recently recommended lifting this 21-year ban to adapt to evolving European geopolitical conflicts.
Investor AB: This Swedish investment powerhouse maintains a core, long-standing industrial ownership stake in Saab AB, which develops advanced military defense tech, aerospace platforms, and naval systems.
Legal & General Group Plc: As one of Europe's largest institutional asset managers, it routinely includes major global aerospace and defense firms across its flagship equity tracker index funds.
2• Pfizer
Institutional Investors: The largest shares of Pfizer are owned by large asset management firms. The top institutional shareholders include:
BlackRock, Inc.
Major arms and defense firms where BlackRock is a top institutional shareholder include:
Lockheed Martin
RTX Corporation (formerly Raytheon Technologies)
Northrop Grumman
The Boeing Company
General Dynamics
BAE Systems (alongside firms like Capital Group, as a top investor in the UK Ministry of Defence's prime supplier)
3. Vanguard Group (Vanguard Capital Management
Essentially a mutual fund operator owned by those who have EFTS in the fund.
Major Defense and Arms Manufacturers Held by Vanguard
Lockheed Martin: Holds roughly a 9.2% institutional stake (valued around $10 billion), making it one of the company's largest shareholders.
RTX Corporation (formerly Raytheon): Major holdings across aerospace and defense index funds.
Northrop Grumman: Substantial passive share in the aerospace and defense giant.
General Dynamics: Held through broad market and defense-related index funds.
Boeing: Significant institutional investment in its commercial and defense divisions.
Palantir Technologies: High percentage institutional ownership in data/military software systems.
Elbit Systems: Holds a multi-percent institutional stake in the international defense electronics and drone manufacturer.
Caterpillar: Held as a major institutional investor in heavy equipment used across industrial and military logistics.
American Outdoor Brands (formerly Smith & Wesson): Holds roughly an 8% stake in the small-arms and firearm manufacturer through small-cap index funds.
4• GlaxoSmithKline (GSK)
Black Rock own almost 10%
5• Roche Swiss Family and shareholders all investments medical research
6• Novartis 97% individual shareholder owned
7• Illumina is owned by
Vanguard Portfolio Management / Vanguard Capital Management (~4.39%)
State Street Corporation (~4.31%)
WCM Investment Management LLC (~4.11%)
Fidelity Management & Research Co. (FMR) (~2.98%)
AQR Capital Management LLC (~2.35%)
• BlackRock, Inc. (major institutional holder)
8• Alnylam
The largest institutional shareholders and mutual fund managers of Alnylam include:
Fidelity Management & Research Co. LLC (FMR LLC): ~11.23%
Capital Research and Management Company / Capital World Investors / Capital Research Global Investors: ~15.7%
BlackRock, Inc.: ~8.15%
Vanguard Portfolio Management LLC: ~4.89%
Vanguard Capital Management LLC: ~4.51%
T. Rowe Price Investment Management, Inc.: ~4.22%
Invesco Advisers, Inc.: ~2.81%
State Street Corporation: ~2.66%
9• Amgen
Largest Institutional Shareholders
The Vanguard Group: 6.5% to 9.9%
BlackRock, Inc. / BlackRock Institutional Trust Company: 5.3% to 6.8%
State Street Corporation / State Street Investment Management:05.4% to 5.6% of shares
Capital Research and Management Company (Capital World / International Investors): 3.5% to 5.4%
Invesco Advisers, Inc. / Invesco Capital Management: 2.1% to 3.0% of shares
10• Biogen
Top Shareholders: Major institutional shareholders include:
Fidelity Management & Research Co. LLC (~12.3%)
PRIMECAP Management Co. (~10.3%)
BlackRock, Inc. (~7.9%)
Vanguard Group
State Street Corp
11• Boehringer Ingelheim 5th generation family pharma business
12• Janssen Research & Development, LLC (facilitated by Johnson & Johnson Innovation)
Institutional shareholders of Johnson and Johnsons
BlackRock Inc.: 8.80%
Vanguard Capital Management LLC: 6.52%
State Street Corporation: 5.55%
13• MSD
The Vanguard Group, Inc.
BlackRock, Inc.
State Street Corp / State Street Global Advisors, Inc.
Wellington Management Group LLP
Bank of America Corp DE
Dimensional Fund Advisors LP
14• Novo Nordisk
Novo Holdings A/S: ~28.32% of shares
BlackRock, Inc.: ~4.11%
Vanguard Capital Management,LLC: ~3.03%
Norges Bank Investment Management: ~1.60%
Dodge & Cox: ~0.83%
Geode Capital Management, LLC: ~0.81%
Amundi Asset Management SAS: ~0.60%
Loomis, Sayles & Company, L.P.: ~0.45%
T. Rowe Price Group, Inc.: ~0.43%
J.P. Morgan Asset Management: ~0.43%
15• Randox Laboratories
Founder owned.
16• Regeneron Genetics Center
Owned by Regeneron Pharmaceuticals
Institutional Investors
Vanguard Capital Management, LLC: Hold 6.4%
BlackRock Institutional Trust Company, N.A.: Holds 5.3%
State Street Investment Management (US): 4.7%
Dodge & Cox: 4.7%
Invesco Capital Management LLC: 3.1%
17• Thermo Fisher Scientific
The largest institutional owners of Thermo Fisher Scientific stock include:
The Vanguard Group: Owns approximately 8.96%
BlackRock Institutional Trust: Owns approximately 4.55% to 8.33%
State Street Investment Management: Owns approximately 4.36%
Capital World Investors: Owns approximately 2.74%
Geode Capital Management: Owns approximately 2.17%
State Street is one of the largest institutional investors in major global aerospace and defense corporations. For example, it is a leading shareholder in companies like Lockheed Martin.
So what will Our Future Health and it's corporate partners with arms industry and healthcare companies interests do for improving people's health? Use AI to predict people at risk of cancer and with hold or vastly increase the cost of their health insurance?
Annalise people's DNA to predict future criminals or determine who receives closer surveillance from the police?
Bring in the same electronic surveillance systems they use on Palestinians in Gaza?
Feed in other corporate data like mobile phone records, education records in order to surveil and control the population?
In April 2026, the data analytics and defense tech giant Palantir Technologies sparked major controversy by publishing a 22-point manifesto on X (formerly Twitter). The post served as a condensed summary of the book The Technological Republic, co-authored by Palantir CEO Alex Karp and head of corporate affairs Nicholas Zamiska. Critics, politicians, and ethics organizations immediately labeled the document a "dystopian plan" and "the ramblings of a supervillain," warning against what they describe as emerging "technofascism" and the privatization of national sovereignty.
The core tenets of Palantir's controversial 22-point vision include:
The Reinstatement of Conscription: The manifesto explicitly advocates that the U.S. government should seriously consider reviving the military draft or universal national service to compel ordinary citizens to support defense initiatives.
Inevitability of AI Warfare: It claims that autonomous AI weapons are an absolute inevitability. It argues the atomic era of deterrence is ending, and that Western democracies have a moral obligation to build killer robots before their adversaries (like Russia and China) do.
Cultural Hierarchy Claims: In one of its most heavily criticized sections, the post states that "some cultures have produced vital advances; others remain dysfunctional and regressive," drawing fierce accusations of civilizational supremacism.
Ending Post-WWII Pacifism: The document calls for an end to the "postwar neutering" of Germany and Japan, pushing for the aggressive rearmament of former Axis powers to bolster Western hard power.
Silicon Valley's Moral Debt: Karp argues that tech companies owe an affirmative "moral debt" to the United States and must abandon consumer-app "decadence" to build weapons, assist in law enforcement, and actively tackle domestic violent crime.
Rejecting Secular Pluralism: It actively promotes a return to religion in public life and characterizes modern Western pluralism as "hollow" and intolerant.
The manifesto provoked intense global backlash, particularly in the UK, where The Guardian reported that Members of Parliament and civil rights groups demanded the immediate termination of Palantir's lucrative public sector infrastructure contracts, including its £330m NHS data platform deal and agreements with the Ministry of Defence. Human rights organizations like the Lemkin Institute for Genocide Prevention also formally condemned the document, citing concerns over Palantir's AI-enabled targeting systems being deployed in active global conflicts.
Are these the kind of people you want in charge of your healthcare and security? They seem to care more about starting a war than they care about our health.
No comments:
Post a Comment